New Maintenance Option Approved for Asthma

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

New Maintenance Option Approved for Asthma (MedPage Today) — The FDA has approved budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) in a single inhaler as a maintenance treatment for asthma in adults and children 12 years and older, AstraZeneca announced Tuesday. Approval of…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button